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Abstract
Background The impact of gender on the clinical char-
acteristics, risk factors, co-morbidities, etiology, treatment
and outcome of acute heart failure in sub-Saharan Africa
has not been described before. The aim of this study was to
evaluate the sex differences in acute heart failure in sub-
Saharan Africa using the data from The sub-Saharan Africa
Survey of Heart Failure (THESUS-HF).
Methods and results 1,006 subjects were recruited into
this prospective multicenter, international observational
heart failure survey. The mean age of total population was
52.4 years (54.0 years for men and 50.7 years for women).
The men were significantly older (p = 0.0045). Men also
presented in poorer NYHA functional class (III and IV),
p = 0.0364). Cigarette smoking and high blood pressure
were significantly commoner in men (17.3 vs. 2.6 % and
60.0 vs. 51.0 % respectively). On the other hand, atrial
fibrillation and valvular heart disease were significantly
more frequent in women. The mean hemoglobin concen-
tration was lower in women compared to men (11.7 vs.
12.6 g/dl, p B 0.0001), while the blood urea and creatinine
levels were higher in men (p\ 0.0001). LV systolic dys-
functional was also seen more in men. Men also had higher
E/A ratio indicating higher LV filling pressure. Outcomes
were similar in both sexes.Electronic supplementary material The online version of this
article (doi:10.1007/s00392-015-0810-y) contains supplementary
material, which is available to authorized users.
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Conclusions Although the outcome of patients admitted
for AHF in sub-Saharan regions is similar in men and
women, some gender differences are apparent suggesting
that in men more emphasis should be put on modifiable life
risk factors, while in women prevention of rheumatic heart
diseases and improved nutrition should be addressed
vigorously.
Keywords Gender  Sex  Heart failure  Africa
Introduction
Heart failure (HF) is a global public health problem [1]. In
the United States alone, more than 5.8 million persons are
affected [2, 3] while over 23-million individuals have been
estimated to have HF worldwide [2]. Furthermore, about
2.4 million hospital admissions in the US are related to HF
as primary and secondary diagnoses every year [3]. The
cost of HF consumes up to 39 million dollars in the US
each year [3]. The data from Europe or Japan are similar
[4]. Prognosis is poor. Mortality risk after HF admission is
11.3 % at 1 month, 33.1 % at 1 year, and over 50 % at
5 years [3].
Major HF registries have shown that women compared
to men are older, have higher frequency of hypertension as
etiological cause, are less likely to have coronary artery
disease (CAD) and have higher mean ejection fraction
(EF), and are also more likely to have heart failure with
normal EF than men [5–9].
Differences between the sexes with respect to the eti-
ology, risk factors, co-morbidities, management and out-
come in patients with HF have not been described in sub-
Saharan African populations.
Study aims
The aim of this report is, therefore, to explore the sex
differences in the clinical characteristics, treatment and
prognosis of HF using the data from The sub-Saharan
Africa Survey of Heart Failure (THESUS-HF) [10].
Materials and methods
Design and setting
The THESUS-HF registry [10] was a prospective multi-
center, international observational survey of HF in 12
Cardiology Units from nine sub-Saharan African countries
which included Cameroon, Ethiopia, Kenya, Mozambique,
Nigeria, Senegal, South Africa, Sudan and Uganda. Ethics
approval was obtained from the institutional ethics com-
mittee, subjects gave informed written consent and the
study conformed to international standards as enshrined by
the Helsinki declaration [11].
Data collection
Data were collected with the use of uniform and stan-
dardized case report forms. The primary cause of HF was
based on the European Society of Cardiology (ESC)
guidelines [12, 13]. An exhaustive materials and methods
of the survey have been published elsewhere [10].
In brief, information obtained included socio-demo-
graphic data, cardiovascular risk factors, medical history/
co-morbid conditions, etiological risk factors, in-hospital
treatment, length of hospital stay (LOS), in-hospital out-
come as well as outcome at 1, 3 and 6 months. Also col-
lected were laboratory investigations such as blood tests,
12-lead ECG and echocardiography.
All the echocardiograms were performed according to
the guidelines of the American Society of Echocardiogra-
phy [14, 15]. An ejection fraction (LV ejection fraction
estimated by Simpson’s method) of C50 % was used to
identify HF with normal ejection fraction.
Subjects were eligible to participate if they were
12 years or older and admitted with clinical symptoms and
signs suggestive of HF. All the cases (de novo or decom-
pensated chronic HF) were confirmed by echocardiogra-
phy. The exclusion criteria included patient with acute ST-
segment myocardial infarction, dialysis-dependent chronic
renal disease, nephrotic syndrome, hepatic failure and other
causes of hypoalbuminemia. Diagnoses of etiologic con-
ditions were based on standard criteria as previously
reported [10]. Specifically peripartum cardiomyopathy
(PPCM) was diagnosed based on published guidelines
[16, 17].
Statistical analysis
Data were managed centrally at Momentum Research Inc.,
Durham, USA. Categorical variables are presented as
proportions, while continuous variables are presented as
mean (SD) or median (inter quartile range—25th and 75th
percentiles).
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Comparison of continuous variables was with 2-tailed,
2-sampled t test while Chi square statistics were used for
the comparison of categorical variables between men and
women. Mortality and readmission rates were estimated
using the Kaplan–Meier method.
The data for the whole cohort were compared according
to gender. This was further analyzed after excluding
women who had PPCM.
A 2-tailed p value of\0.05 was assumed as statistically
significant. SAS software (SAS, version 9.2; SAS Institute,
Inc. USA) was used for analysis.
Results
One thousand and six subjects were recruited into the study
(494 men and 511 women, the sex of one subject was not
reported). The mean age of study population was
52.4 years (54.0 years for men and 50.7 years for
women).The men were significantly older (p = 0.0045),
but not so when 74 women with PPCM were excluded
(p = 0.647) (Table 1).
The age distribution according to gender is shown in
Figs. 1 and 2. Over 98 % of the cohort was Blacks. The
mean body mass index was 24.9 kg/m2 and this was similar
in both sexes even after excluding those with PPCM.
History of previous admission for HF was commoner in
men (24.7 vs. 19.6 %, p = 0.0502, 0.286 after excluding
women with PPCM). Men also had a poorer NYHA
functional class (III and IV) 1 month before admission,
p = 0.0364, 0.0220 after excluding women with PPCM).
In terms of cardiovascular risk factors and past medical
history, cigarette smoking and high blood pressure were
significantly reported more in men (17.3 vs. 2.6 and 60.0
vs. 51.0 % respectively). The gender difference in high
blood pressure prevalence became insignificant after
removing women with PPCM.
On the other hand, atrial fibrillation and valvular heart
disease were significantly more frequent in women, espe-
cially when women with PPCM were excluded (Table 1).
The mean heart and respiratory rates were significantly
higher in women (105.7 vs. 101.6 beats/min, 31.3 vs. 30.0
cycles/min, respectively).
Table 2 shows the baseline laboratory profile of the
subjects on admission in terms of gender.
The mean hemoglobin concentration was lower in
women compared to men (11.7 vs. 12.6 g/dl, p B 0.0001)
while the blood urea and creatinine levels were higher in
men (p\ 0.0001).
Table 3 and supplemental Table 1 depict the sex dis-
tribution of echocardiographic variables. Virtually, all the
echocardiographic parameters were significantly higher in
men compared to women.
In terms of valvular dysfunction, aortic lesions were
more frequent in men. Left ventricular (LV) systolic dys-
functional was also seen more in men. Men also had higher
E/A ratio indicating higher LV filling pressure. LV ejection
fraction was also significantly lower in men.
Etiology-wise, (Table 4), women had higher rates of
rheumatic heart disease, endomyocardial fibrosis and
human immunodeficiency virus (HIV)-associated cardio-
myopathy while hypertensive HF, dilated cardiomyopathy
and ischemic heart disease were common in men.
The major 12-lead ECG findings according to gender are
shown in supplemental Table 2. As previously stated atrial
fibrillation was significantly commoner in women (27.5 vs.
19.5 %, p = 0.0338), especially after excluding those
women with PPCM (p = 0.0049) while ST-T changes
were observed more in men (36.9 vs. 25.8 %, p = 0.0066
and 0.0002 after excluding those with PPCM).
Medications
Supplemental Tables 3 and 4 show the medications on
admission and discharge, respectively, according to gender.
Women more frequently received digitalis compounds than
men (15.8 vs. 11.4 %, p = 0.0416).
Outcome
Table 5 shows the outcome variables. These are similar in
men and women even after excluding women with PPCM.
Figure 3 shows the survival curves according to gender.
Discussion
Our study revealed some sex differences in African sub-
jects with AHF. Men were older than the women. HF was
generally commoner in women especially before the age of
50 years. From the age of 50–70 years, it tended to be
more frequent in men. Previous history of HF (acute on
chronic HF) was seen more in men. The burden of CV risk
factors such as hypertension and cigarette smoking was
higher in men. Anemia was reported more frequently in
women while renal impairment was more frequent in men.
Echocardiographic parameters were more abnormal in men
and there were some differences in the etiology of HF in
men and women. Atrial fibrillation was commoner in
women while left ventricular hypertrophy (LVH), ECG
features of ischemic and ST-T abnormalities were com-
moner in men. Although health outcomes were slightly
worse in men, these were not statistically significant.
In the Euro-HF survey, HF was less frequently diag-
nosed in women (39 %) [18]. Women were generally older
than men in all the HF registries in high-income countries
Clin Res Cardiol (2015) 104:481–490 483
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Table 1 Baseline socio-demographic characteristics profile of the patients by gender
Characteristic Total (n = 1,006) Male (n = 494) Female
(n = 511)
P value* Female (excluding
peripartum CM)
(n = 437)
P value**
Age (years), mean (SD),
25th percentile, median,
75th percentile
52.4 (18.3) 39.0,
55.0, 67.0
54.0 (16.9) 43.0,
55.0, 67.0
50.7 (19.5) 33.0,
53.0, 67.0
0.0045 54.6 (18.3) 41.0,
58.0, 70.0
0.6473
[65 years (n/%) 269 (26.7 %) 134 (27.1 %) 135 (26.4 %) 0.8003 135 (30.9 %) 0.2057
Race
Black (n/%) 984 (98.5 %) 486 (98.8 %) 497 (98.2 %) 0.4680 423 (97.9 %) 0.2999
BMI (kg/m2), mean (SD) 24.9 (5.8) 24.7 (5.0) 25.1 (6.5) 0.2583 25.4 (6.7) 0.0604
Admitted for HF in
12 months prior to
admission
222 (22.1 %) 122 (24.7 %) 100 (19.6 %) 0.0502 95 (21.7 %) 0.2868
No. of HF admissions in
prior 12 months, mean
(SD)
0.37 (0.78) 0.41 (0.77) 0.34 (0.78) 0.1523 0.38 (0.82) 0.5280
NYHA class 1 month before admission (n/%)
I 121 (18.1 %) 59 (18.0 %) 62 (18.2 %) 0.0364 49 (16.1 %) 0.0220
II 303 (45.3 %) 133 (40.6 %) 170 (50.0 %) 157 (51.6 %)
III 217 (32.4 %) 118 (36.0 %) 98 (28.8 %) 90 (29.6 %)
IV 28 (4.2 %) 18 (5.5 %) 10 (2.9 %) 8 (2.6 %)
CV risk factors, past medical history
Smoking (n/%) 98 (9.8 %) 85 (17.3 %) 13 (2.6 %) \0.0001 12 (2.8 %) \0.0001
Hypertension (n/%) 556 (55.5 %) 296 (60.0 %) 259 (51.0 %) 0.0040 255 (58.6 %) 0.6603
Peripheral vascular
disease (n/%)
12 (1.2 %) 9 (1.8 %) 3 (0.6 %) 0.0732 3 (0.7 %) 0.1282
Stroke (n/%) 25 (2.5 %) 10 (2.0 %) 15 (2.9 %) 0.3513 11 (2.5 %) 0.6095
Hyperlipidemia (n/%) 90 (9.2 %) 52 (10.8 %) 38 (7.6 %) 0.0852 35 (8.2 %) 0.1888
Atrial fibrillation (n/%) 184 (18.4 %) 77 (15.7 %) 107 (21.1 %) 0.0283 107 (24.7 %) 0.0006
Ischemic heart disease
(n/%)
82 (8.2 %) 46 (9.3 %) 36 (7.1 %) 0.1893 36 (8.3 %) 0.5648
Valvular heart disease
(n/%)
272 (27.2 %) 113 (22.9 %) 159 (31.4 %) 0.0025 153 (35.4 %) \0.0001
Cardiomyopathy (n/%) 416 (41.9 %) 200 (40.9 %) 216 (42.9 %) 0.5320 158 (36.7 %) 0.1974
Cor pulmonale (n/%) 72 (7.2 %) 36 (7.4 %) 36 (7.1 %) 0.8872 35 (8.1 %) 0.6744
Pacemaker (n/%) 4 (0.4 %) 4 (0.8 %) 0 (0.0 %) 0.0580 0 (0 %) 0.1270
Pericardial disease (n/%) 53 (5.3 %) 29 (5.9 %) 24 (4.7 %) 0.4132 20 (4.6 %) 0.3875
Diabetes mellitus (n/%) 114 (11.4 %) 58 (11.8 %) 56 (11.0 %) 0.6790 52 (11.9 %) 0.9584
Depression (n/%) 33 (3.3 %) 15 (3.0 %) 18 (3.5 %) 0.6572 18 (4.1 %) 0.3654
Dementia (n/%) 22 (2.2 %) 9 (1.8 %) 13 (2.6 %) 0.4342 13 (3.0 %) 0.2475
Malignancy (n/%) 13 (1.3 %) 5 (1.0 %) 8 (1.6 %) 0.4399 8 (1.8 %) 0.2896
Symptoms on admission
Orthopnea, mean (SD)a 2.31 (0.76) 2.33 (0.76) 2.29 (0.75) 0.5298 2.24 (0.77) 0.0961
Signs on admission
Peripheral edema, mean
(SD)b
1.83 (1.04) 1.87 (1.05) 1.78 (1.03) 0.1844 1.73 (1.05) 0.0394
Rales, mean (SD)c 1.68 (0.92) 1.66 (0.90) 1.70 (0.94) 0.4981 1.68 (0.97) 0.7197
Temperature (oC),
mean (SD)
36.7 (0.6) 36.7 (0.7) 36.6 (0.6) 0.1980 36.6 (0.6) 0.1629
Respiratory rate (changed
to b/min), mean (SD)
30.7 (7.9) 30.0 (7.5) 31.3 (8.3) 0.0120 31.1 (8.6) 0.0484
484 Clin Res Cardiol (2015) 104:481–490
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[5, 6, 8, 18]. For example, in the Japanese HF registry,
female patients were a mean of 5.7 years older than the
men [8]. In the acute heart failure database (AHEAD), the
mean age of men and women was 68–70 and 73–75 years,
respectively [19]. The finding of greater frequency of de
novo HF in women in this study is consistent with the
observation in the Euro-HF survey; however, our finding
may have been driven by the frequency of PPCM [18]. The
differences may also be related to the population structure
in Africa compared to that of high-income countries of the
world. The African population is very young compared to
high-income countries where the age of onset of heart
disease is generally after the age of 65 years [20, 21].
Cardiovascular risk factors such as, hypertension, ciga-
rette smoking, coronary artery disease and chronic
obstructive pulmonary disease (COPD) were seen more in
Fig. 1 Age distribution of the
subjects by gender
Table 1 continued
Characteristic Total (n = 1,006) Male (n = 494) Female
(n = 511)
P value* Female (excluding
peripartum CM)
(n = 437)
P value**
Heart rate, mean (SD) 103.7 (21.6) 101.6 (21.4) 105.7 (21.6) 0.0029 103.8 (21.9) 0.1316
Systolic blood pressure
(mmHg), mean (SD)
130.4 (33.5) 132.4 (33.7) 128.5 (33.4) 0.0611 131.4 (34.0) 0.6425
Diastolic blood pressure
(mmHg), mean (SD)
84.3 (20.9) 85.5 (21.2) 83.2 (20.7) 0.0840 84.1 (21.3) 0.3093
Pulse pressure (mmHg),
mean (SD)
46.2 (19.7) 47.0 (19.4) 45.4 (20.0) 0.1982 47.3 (20.4) 0.8037
Oxygen saturation, mean
(SD)
93.3 (6.4) 93.3 (5.5) 93.2 (7.0) 0.8442 93.1 (7.4) 0.6671
Values reported as mean (SD) for continuous variables and n (%) for categorical. Median, 25th, and 75th percentiles given for skewed data
a Orthopnea scored as 0-none, 1–1 pillow (10 cm), 2–2 pillows (20 cm), 3–3 pillows ([30 cm)
b Peripheral edema scored as 0-complete absence of skin indentation with mild digital pressure in all dependent areas, 1-indention of skin that
resolves over 10–15 s, 2-indention of skin is easily created with limited pressure and disappears slowly (15–30 s or more), 3-large areas of
indentation easily produced and slow to resolve ([30 s)
c Rales scores as 0-no rales after clearing with cough, 1-moist or dry rales heard in lower 1/3 of 1 or both lung fields that persist after cough,
2-moist or dry rales heard throughout the lower half to 2/3 of 1 or both lung fields, 3-moist or dry rales heard throughout both lung fields
* (Chi Square for categorical, t test for continuous) male versus female
** (Chi Square for categorical, t test for continuous) male versus female (excluding peripartum CM)
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men. The higher rates of COPD in men may be related to
higher rate of smoking. Occupations related to the devel-
opment of COPD such as mining are also associated with
men in Africa. Higher frequency of anemia in women may
be related to menstruation as well as poorer nutrition.
In the Euro-HF survey, hypertension (67.4 vs.
59.4 %), diabetes (35 vs. 31.4 %) and anemia (18.5 vs.
12.4 %) were commoner in women [18]. As has been
observed by other AHF registries [5 8 18], renal
impairment is more frequent in men. This may be related
to longer duration of CV risk factors such as hyperten-
sion, higher frequency of acute or chronic HF as well as
higher burden of peripheral vascular disease in men
compared to women.
Men also had higher frequency of severe symptoms
(New York Heart Association (NYHA) classes III and IV),
Fig. 2 Age distribution of the
subjects by gender (females
excluding peripartum CM)
Table 2 Baseline laboratory profile of the subjects on admission according to gender
Variable Total
(n = 1,006)
Male
(n = 494)
Female
(n = 511)
P value* Female (excluding
peripartum CM)
(n = 437)
P value**
Blood tests
Sodium (mmol/L), mean (SD) 946, 135.1 (6.6) 463, 134.9 (6.5) 482, 135.3 (6.8) 0.3294 416, 135.4 (6.8) 0.2818
Glucose (mg/dl), mean (SD) 878, 109.7 (49.7) 442, 109.7 (44.0) 435, 109.5 (54.9) 0.9420 380, 112.5 (57.6) 0.4453
Hemoglobin (g/dl), mean (SD) 967, 12.2 (2.4) 476, 12.6 (2.6) 490, 11.7 (2.2) \0.0001 418, 11.8 (2.2) \0.0001
Total white cell count/mm3,
mean (SD)
963, 7,699.3
(4,091.7)
472, 7,484.1
(3,505.0)
490, 7,914.2
(4,580.9)
0.1015 418, 7,972.0
(4,743.4)
0.0847
Lymphocytes (%), mean (SD) 839, 30.3 (13.4) 417, 29.8 (12.9) 421, 30.9 (13.8) 0.2497 366, 30.3 (13.7) 0.6222
Blood urea (mg/dl), mean (SD) 951, 35.6 (33.1) 466, 41.0 (37.2) 484, 30.4 (27.7) \0.0001 417, 31.9 (29.2) \0.0001
Creatinine (mg/dl), mean (SD) 964, 1.39 (1.05) 471, 1.53 (1.11) 492, 1.26 (0.97) \0.0001 421, 1.3 (1.0) 0.0005
Total cholesterol (mg/dl),
mean (SD)
649, 157.6 (54.2) 318, 160.0 (59.0) 331, 155.2 (49.1) 0.2648 279, 157.8 (50.3) 0.6208
Triglyceride (mg/dl), mean (SD) 640, 106.2 (53.9) 316, 109.8 (56.7) 324, 102.7 (50.9) 0.0918 274, 103.5 (53.5) 0.1678
Peak creatine kinase (IU/L),
mean (SD)
245, 232.2 (447.7) 108, 259.4 (412.6) 137, 210.8 (473.9) 0.4004 121, 222.5 (501.0) 0.5423
Peak CK- MB (IU/L), mean (SD) 175, 37.4 (76.0) 83, 39.1 (83.9) 92, 35.9 (68.6) 0.7831 88, 36.0 (70.1) 0.7960
* (t test) male versus female
** (t test) male versus female (excluding peripartum CM)
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higher rates of left atrial dilatation, LVH and LV systolic
and diastolic dysfunction.
On the other hand, HF with normal EF was reported
more often in women. This is consistent with previous
reports. In the Euro-HF survey II, HF with preserved EF
was observed twice as often in women than in men [18]. In
another report, HF with normal EF was noted in up to 73 %
of women [22]. In high-income countries, this was attrib-
uted to higher frequency of hypertension and older age in
women. This is not the case in our study. The reason for
our observation may be related to higher burden of CV risk
factors as well as advanced heart disease in men compared
to women.
In terms of etiological risk factor for HF, except for
valvular heart disease, all the other factors were more
frequent in men. Higher burden of valvular heart disease in
women has been reported by other workers [5, 18, 22]. This
suggests that in men more emphasis should be placed on
modification of risk factors while in women prevention of
rheumatic heart diseases and improved nutrition should be
addressed vigorously.
ECG abnormalities such as atrial fibrillation, ventricular
extrasystoles and bundle-branch block were commoner in
women while LVH, Q-waves and ST-T changes were more
frequent in men.
The higher rates of arrhythmias especially atrial fibril-
lation in women may be related to the higher frequency of
valvular heart disease [23, 24]. Hypertension and ischemic
heart disease which are diagnosed more frequently in men
may explain the higher burden of LVH and ST-T abnor-
malities in them [25–28].
On admission but not discharge, digitalis compounds were
prescribed more in women, probably because of the higher
prevalence of atrial fibrillation within this group. On the other
hand, aspirin was prescribed more to men, possibly because
of the greater frequency of ischemic changes on ECG. This
picture has been documented by other workers [5, 8, 18].
Health outcomes such as length of stay (LOS), intra-
hospital mortality rates, 30-day, 90-day and 180-day mor-
tality were slightly higher in men compared to women.
This, however, did not reach statistical significance. This is
similar to the observation in the Japanese HF registry and
Table 3 Echocardiography by gender (excluding PPCM)
Echocardiography All (n = 954) Men (n = 469) Female
(excluding
peripartum CM)
(n = 413)
OR (95 % CI) for
categorical, mean
difference (95 % CI)
for continuous
P value (Chi square
for categorical, t test
for continuous)
LA diameter (mm), mean (SD) 47.1 (9.1) 47.8 (8.6) 47.2 (9.7) -0.55 (-1.80, 0.71) 0.3922
LA area (mm2), mean (SD) 2,776.1 (934.7) 2,880.2 (872.3) 2,703.8 (1,012.4) -176.40 (-343.90, -8.93) 0.0390
IVSTd (mm), mean (SD) 11.2 (3.2) 11.7 (3.2) 11.2 (3.1) -0.49 (-0.91, -0.06) 0.0250
PWTd (mm), mean (SD) 10.7 (2.9) 11.2 (2.9) 10.7 (2.7) -0.50 (-0.88, -0.16) 0.0106
LVIDd (mm), mean (SD) 57.7 (11.6) 59.6 (11.4) 55.0 (11.7) -4.55 (-6.08, -3.01) \0.0001
LVIDs (mm), mean (SD) 46.1 (13.2) 48.2 (12.9) 42.5 (13.1) -5.73 (-7.46, -4.00) \0.0001
EA_ratio, mean (SD) 2.02 (2.33) 2.26 (3.00) 1.73 (1.16) -0.53 (-0.89, -0.17) 0.0039
E-wave deceleration time (ms),
mean (SD)
150.2 (92.9) 147.5 (98.2) 162.0 (92.0) 14.49 (0.22, 28.76) 0.0466
A-wave duration (ms),
mean (SD)
126.1 (45.0) 124.3 (42.0) 132.8 (48.8) 8.53 (0.30, 16.77) 0.0423
Aortic stenosis (n/%)a 24 (2.6 %) 15 (3.3 %) 9 (2.2 %) 1.51 (0.65, 3.48) 0.3339
Aortic regurgitation (n/%)a 83 (8.9 %) 50 (10.9 %) 31 (7.6 %) 1.49 (0.93, 2.38) 0.0961
Mitral stenosis (n/%)a 51 (5.5 %) 19 (4.2 %) 32 (8.0 %) 0.51 (0.28, 0.91) 0.0206
Mitral regurgitation (n/%)a 366 (38.7 %) 178 (38.5 %) 170 (41.4 %) 0.89 (0.68, 1.17) 0.3932
Tricuspid regurgitation (n/%)a 266 (28.2 %) 136 (29.4 %) 114 (27.8 %) 1.08 (0.81, 1.45) 0.5947
Pericardial effusion (n/%) 31 (3.3 %) 13 (2.9 %) 16 (4.0 %) 0.71 (0.34, 1.51) 0.3748
Ejection fraction, mean (SD) 39.4 (16.2) 37.5 (15.7) 43.4 (16.1) 5.85 (3.69, 8.01) \0.0001
LVEF C45 % (n/%) 317 (33.2 %) 134 (28.6 %) 180 (43.6 %) 0.52 (0.39, 0.68) \0.0001
LVEF 30–44 % (n/%) 299 (31.3 %) 155 (33.1 %) 128 (31.0 %) 1.10 (0.83, 1.46)
LVEF\30 % (n/%) 278 (29.1 %) 152 (32.4 %) 85 (20.6 %) 1.85 (1.36, 2.52)
Subset of patients with echocardiography within 4 weeks prior to 2 weeks after admission
Mean (SD) or n (%) provided for continuous and categorical variable, respectively. t test used to compare genders for continuous variables and
Chi square test provided for categorical comparisons
a Percentages reported as those with moderate/severe vs. mild/none
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in the Euro-HF survey II [18] and the United States reg-
istries [5, 29]. However, adjusted mortality was better in
women in the AHEAD registry [19] and some other studies
[30, 31].
Limitations
The fact that our registry was conducted in tertiary hospi-
tals may indicate that our findings may not reflect what
happens in the secondary or primary healthcare services in
these African countries. The data may not, therefore, be
inclusive and could only represent what happens in these
tertiary institutions.
Confirmation of final diagnoses as well as echocardio-
graphic parameters was done locally which is also a limi-
tation. Invasive cardiac procedures were not available in
many of the centers. Many cases of ischemic heart disease
may have been missed. In addition, standard cardiac pro-
cedures performed in these subjects were not captured by
our study.
In conclusion, there are unique gender differences in the
presentation of HF in sub-Saharan Africa. Male subjects
are generally older than women which are the reverse in
high-income countries where women are about 6 years
older than men. Before the age of 50 years, HF was
diagnosed more often in women, but thereafter in men.
Except for valvular heart disease and peripartum cardio-
Table 4 Primary etiology by gender
Etiology Total (n = 1,006) Male (n = 494) Female (n = 511) Female (excluding
peripartum CM) (n = 437)
Hypertensive CMP (n/%) 396 (40.4 %) 219 (45.3 %) 176 (35.6 %) 176 (41.8 %)
Idiopathic dilated CMP (n/%) 136 (13.9 %) 89 (18.4 %) 47 (9.5 %) 47 (11.2 %)
Rheumatic heart disease (n/%) 140 (14.3 %) 54 (11.2 %) 86 (17.4 %) 86 (20.4 %)
Ischemic heart disease (n/%) 77 (7.9 %) 48 (9.9 %) 29 (5.9 %) 29 (6.9 %)
Peripartum cardiomyopathy (n/%) 74 (7.7 %) 0 74 (15.0 %) –
Pericardial effusion/tamponade (n/%) 47 (4.8 %) 25 (5.2 %) 22 (4.4 %) 22 (5.2 %)
HIV cardiomyopathy (n/%) 23 (2.4 %) 12 (2.5 %) 11 (2.2 %) 11 (2.6 %)
Endomyocardial fibrosis (n/%) 13 (1.3 %) 3 (0.6 %) 10 (2.0 %) 10 (2.4 %)
Other (n/%) 73 (7.5 %) 33 (6.8 %) 40 (8.1 %) 40 (9.5 %)
Table 5 Outcome variables according to gender
Outcome All
(n = 1,006)
Men
(n = 494)
Women
(n = 511)
P value Female (excluding
peripartum CM)
(n = 437)
P value**
Length of hospital staya 9.22 (9.29) 9.39 (10.37) 9.07 (8.14) 0.6081 9.00 (8.08) 0.5468
Intrahospital mortality rateb 42 (4.2 %) 24 (4.9 %) 18 (3.5 %) 0.2930 15 (3.4 %) 0.2817
All-cause mortality through 30 daysc 54 (5.7 %) 30 (6.4 %) 24 (5.0 %) 0.3481 20 (4.9 %) 0.3311
All-cause mortality through 90 daysc 115 (13.1 %) 59 (13.5 %) 56 (12.6 %) 0.6483 44 (11.7 %) 0.3914
All-cause mortality through 180 daysc 151 (17.8 %) 77 (18.3 %) 74 (17.4 %) 0.6393 60 (16.6 %) 0.4399
All-cause readmission through 30 daysc 24 (2.8 %) 12 (2.8 %) 12 (2.7 %) 0.9308 11 (2.9 %) 0.9293
All-cause readmission through 90 daysc 111 (14.1 %) 56 (14.4 %) 55 (13.8 %) 0.7473 50 (14.7 %) 0.9866
All-cause readmission through 180 daysc 157 (20.8 %) 74 (19.9 %) 83 (21.8 %) 0.6405 77 (23.6 %) 0.3221
All-cause death or readmission through
60 daysc
138 (15.6 %) 73 (16.6 %) 65 (14.5 %) 0.3732 54 (14.2 %) 0.3208
a Mean (SD). P value provided from t test
b N (%). P value provided from v2 test
c N (KM %). P value provided from log-rank test
* Male versus female
** Male versus female (excluding peripartum CM)
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myopathy, other etiological risk factors were commoner in
men. Men also had higher frequency of systolic HF, renal
dysfunction, but lower frequency of anemia than women.
Drug prescriptions at admission or discharge were rela-
tively similar. Outcomes were slightly worse in men, but
these were not statistically significant.
These findings call for individualized care for patients in
the region especially the male gender that is likely to have
multiple cardiovascular risk factors.
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